BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9377577)

  • 1. Genomic imprinting and Igf2 influence liver tumorigenesis and loss of heterozygosity in SV40 T antigen transgenic mice.
    Haddad R; Held WA
    Cancer Res; 1997 Oct; 57(20):4615-23. PubMed ID: 9377577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity of imprinted genes in SV40 t/T antigen-induced hepatocellular carcinomas.
    Casola S; Ungaro P; Pedone PV; Lazzaro D; Fattori E; Ciliberto G; Zarrilli R; Bruni CB; Riccio A
    Oncogene; 1995 Aug; 11(4):711-21. PubMed ID: 7651735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of the maternally imprinted IGF2 allele in TGFalpha induced hepatocellular carcinomas in mice.
    Harris TM; Rogler LE; Rogler CE
    Oncogene; 1998 Jan; 16(2):203-9. PubMed ID: 9464538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of liver tumorigenesis in SV40 T antigen transgenic mice implies a role for imprinted genes.
    Held WA; Pazik J; O'Brien JG; Kerns K; Gobey M; Meis R; Kenny L; Rustum Y
    Cancer Res; 1994 Dec; 54(24):6489-95. PubMed ID: 7987847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
    Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
    Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
    Davies SM
    Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic imprinting and Wilms' tumor.
    Moulton T; Chung WY; Yuan L; Hensle T; Waber P; Nisen P; Tycko B
    Med Pediatr Oncol; 1996 Nov; 27(5):476-83. PubMed ID: 8827077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis.
    Cui H; Hedborg F; He L; Nordenskjöld A; Sandstedt B; Pfeifer-Ohlsson S; Ohlsson R
    Cancer Res; 1997 Oct; 57(20):4469-73. PubMed ID: 9377554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble IGF2 receptor rescues Apc(Min/+) intestinal adenoma progression induced by Igf2 loss of imprinting.
    Harper J; Burns JL; Foulstone EJ; Pignatelli M; Zaina S; Hassan AB
    Cancer Res; 2006 Feb; 66(4):1940-8. PubMed ID: 16488992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas.
    Wu HK; Squire JA; Catzavelos CG; Weksberg R
    Biochem Biophys Res Commun; 1997 Jun; 235(1):123-9. PubMed ID: 9196048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
    Vu TH; Chuyen NV; Li T; Hoffman AR
    Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis.
    Vernucci M; Cerrato F; Besnard N; Casola S; Pedone PV; Bruni CB; Riccio A
    Oncogene; 2000 Dec; 19(54):6376-85. PubMed ID: 11175353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enhancer element at the Igf2/H19 locus drives gene expression in both imprinted and non-imprinted tissues.
    Charalambous M; Menheniott TR; Bennett WR; Kelly SM; Dell G; Dandolo L; Ward A
    Dev Biol; 2004 Jul; 271(2):488-97. PubMed ID: 15223349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of H19 does not influence the timing of replication of the Igf2/H19 imprinted region.
    Windham CQ; Jones PA
    Dev Genet; 1997; 20(1):29-35. PubMed ID: 9094209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFalpha reactivates imprinted Igf2 in the parthenogenetic mice embryos and placenta.
    Rostam Zadehl J; Penkov LI; Klimov EA; Platonov ES; Sulimova GE
    Genetika; 2005 Oct; 41(10):1387-91. PubMed ID: 16316011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Location of enhancers is essential for the imprinting of H19 and Igf2 genes.
    Webber AL; Ingram RS; Levorse JM; Tilghman SM
    Nature; 1998 Feb; 391(6668):711-5. PubMed ID: 9490417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma.
    Yun K; Jinno Y; Sohda T; Niikawa N; Ikeda T
    J Pathol; 1998 May; 185(1):91-8. PubMed ID: 9713365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paternally derived H19 is differentially expressed in malignant and nonmalignant trophoblast.
    Walsh C; Miller SJ; Flam F; Fisher RA; Ohlsson R
    Cancer Res; 1995 Mar; 55(5):1111-6. PubMed ID: 7866996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation status of putative differentially methylated regions of porcine IGF2 and H19.
    Han DW; Im YB; Do JT; Gupta MK; Uhm SJ; Kim JH; Schöler HR; Lee HT
    Mol Reprod Dev; 2008 May; 75(5):777-84. PubMed ID: 18247333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of imprinting of the insulin-like growth factor II gene in mouse hepatocellular carcinoma cell lines.
    Ooasa T; Karasaki H; Kanda H; Nomura K; Kitagawa T; Ogawa K
    Mol Carcinog; 1998 Dec; 23(4):248-53. PubMed ID: 9869454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.